Our March 2020 edition is live!

Our March 2020 issue includes partnering companies focused on developing therapies for oncology.

Like Comment

Our first issue of the year covers companies focusing on new therapies for the treatment of oncology. The feature editorials cover recent oncology dealmaking trends and a review of the M&As that took place in 2019.

Read the full issue here 

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.